These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 15565912)

  • 1. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites.
    Inceboz T; Inceboz U; Ozturk S
    J Chemother; 2004 Oct; 16(5):459-62. PubMed ID: 15565912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
    Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A
    Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.
    Meri T; Jokiranta TS; Suhonen L; Meri S
    J Clin Microbiol; 2000 Feb; 38(2):763-7. PubMed ID: 10655382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New acquisitions in the therapy of Trichomonas vaginalis vaginitis].
    Sandront-Degée M; Werbrouck-Navette J; Lambotte R
    Rev Med Liege; 1975 Sep; 30(17):560-2. PubMed ID: 1166170
    [No Abstract]   [Full Text] [Related]  

  • 5. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.
    Sobel JD; Nyirjesy P; Brown W
    Clin Infect Dis; 2001 Oct; 33(8):1341-6. PubMed ID: 11565074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro sensitivity of Trichomonas vaginalis to DNA topoisomerase II inhibitors.
    Petmitr PC; Ramdja M; Kajorndechakiat S
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):118-22. PubMed ID: 11023077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenical pessaries in the treatment of metronidazole-resistant Trichomonas vaginalis.
    Walker PP; Hall RE; Wilson JD
    Int J STD AIDS; 1997 Jul; 8(7):473. PubMed ID: 9228600
    [No Abstract]   [Full Text] [Related]  

  • 8. A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.
    Ray DK; Tendulkar JS; Shrivastava VB; Datta AK; Nagarajan K
    J Antimicrob Chemother; 1984 Oct; 14(4):423-6. PubMed ID: 6334072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
    Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
    Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Mtshali A; Ngcapu S; Govender K; Sturm AW; Moodley P; Joubert BC
    Microbiol Spectr; 2022 Aug; 10(4):e0091222. PubMed ID: 35863010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
    Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
    Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitrichomonal properties of derivatives of ethers containing amine and halogenarylalkyl groups].
    Białasiewicz D; Kotełko B; Kurnatowska A; Kwaśniewska J
    Wiad Parazytol; 1990; 36(5-6):281-5. PubMed ID: 2131703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis--A case report.
    Kulda J; Vojtĕchovská M; Tachezy J; Demes P; Kunzová E
    Br J Vener Dis; 1982 Dec; 58(6):394-9. PubMed ID: 6983379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients.
    Hager WD
    Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effect of a plant alkaloid (berberine derived from Berberis aristata) on Trichomonas vaginalis in vitro.
    Soffar SA; Metwali DM; Abdel-Aziz SS; el-Wakil HS; Saad GA
    J Egypt Soc Parasitol; 2001 Dec; 31(3):893-904 + 1p plate. PubMed ID: 11775115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological Changes of Trichomonas vaginalis Treated by Ornidazole: An In-Vitro Study.
    Cakan H; Polat E; Arda O; Cepni I; Dirican A; Sirekbasan S
    Clin Lab; 2016; 62(5):793-800. PubMed ID: 27349003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain.
    Pérez S; Fernández-Verdugo A; Pérez F; Vázquez F
    Sex Transm Dis; 2001 Feb; 28(2):115-6. PubMed ID: 11234785
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
    Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
    Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
    Mammen-Tobin A; Wilson JD
    Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.